Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder
Open accessAbstract
OBJECTIVES: Elucidating the biological mechanisms involved in attention-deficit/hyperactivity disorder (ADHD) has been challenging. Relatively unexplored is the fact that these mechanisms can differ with age. METHODS: We present an overview on the major differences between children and adults with ADHD, describing several studies from genomics to metabolomics performed in ADHD children and in adults (cADHD and aADHD, respectively). A systematic search (up until February 2016) was conducted. RESULTS: From a PRISMA flow-chart, a total of 350 and 91 genomics and metabolomics studies were found to be elligible for cADHD and aADHD, respectively. For children, associations were found for genes belonging to dopaminergic (SLC6A3, DRD4 and MAOA) and neurodevelopmental (LPHN3 and DIRAS2) systems and OPRM1 (Yates corrected P = 0.016; OR = 2.27 95%CI: 1.15-4.47). Studies of adults have implicated circadian rhythms genes, HTR2A, MAOB and a more generic neurodevelopmental/neurite outgrowth network (BCHE, SNAP25, BAIAP2, NOS1/NO, KCNIP4 and SPOCK3; Yates corrected P = 0.007; OR = 3.30 95%CI: 1.33-8.29). In common among cADHD and aADHD, the most significant findings are for oxidative stress proteins (MAD, SOD, PON1, ARES, TOS, TAS and OSI), and, in the second level, DISC1, DBH, DDC, microRNA and adiponectin. CONCLUSIONS: Through a convergent functional genomics, this review contributes to clarification of which genetic/biological mechanisms differ with age. The effects of some genes do not change throughout the lifetime, whereas others are linked to age-specific stages. Additional research and further studies are needed to generate firmer conclusions that might someday be useful for predicting the remission and persistence of the disorder. Despite the limitations, some of these genes/proteins could be potential useful biomarkers to discriminate cADHD from aADHD.
AI snapshot
Written from the paper’s full text.
TL;DR
This review uses convergent functional genomics to compare genetic and peripheral biomarker findings between children and adults with ADHD. It reports age-specific gene/protein sets and a smaller common set, suggesting partly differential etiological pathways across the lifespan.
Key findings
- In children with ADHD (cADHD), specific associations were reported for dopaminergic and neurodevelopmental genes: SLC6A3, DRD4, MAOA, LPHN3, DIRAS2, and OPRM1 (Yates Corrected p=0.016; OR=2.27, 95%CI:1.15–4.47).
- In adults with ADHD (aADHD), specific associations were reported for circadian rhythm genes, HTR2A, MAOB, and a neurodevelopmental/neurite outgrowth network including BCHE, SNAP25, BAIAP2, NOS1/NO, KCNIP4, and SPOCK3 (Yates Corrected p=0.007; OR=3.30, 95%CI:1.33–8.29).
- Findings common to cADHD and aADHD were most significant for oxidative stress proteins (MAD, SOD, PON1, ARES, TOS, TAS, OSI), followed at a second level by DISC1, DBH, DDC, microRNA, and adiponectin.
- The PRISMA flow-chart identified 350 eligible genomics and metabolomics studies for cADHD and 91 for aADHD; one aADHD pilot combining SLC6A3, DRD5, TPH1, and SNAP25 expression reported sensitivity and specificity over 80%.
Methods
- Design: review/overview of genomics (linkage, candidate gene association, SNP/CNV GWAS, expression) and metabolomics studies in children and adults with ADHD.
- Data: systematic search up until February 2016; eligibility yielded 350 studies for cADHD and 91 for aADHD.
- Analysis: convergent functional genomics with summary of positive/negative findings and statistical results for common and specific pathways, reported in Tables S1 and S2; detailed search strategy, inclusion/exclusion criteria, and statistical analyses are in supplementary material.
Limitations
- The paper states that meta-analyses were divided into single studies to give the same weight to different findings; that more genes were associated with aADHD because SNP/CNV GWAS studies available for a gene mostly showed negative results in children; and that several genes/proteins require replication (OPRM1, adiponectin, KCNIP4, SPOCK3, microRNA, DIRAS2, DISC1, ZNF804A, ASTN2, GPC5/6, kynurenine pathway, CTNNA2, MAP1B, ITGAE/ITGA11).
- The paper also states that all genetic studies in childhood and/or adulthood ADHD so far lack power and have not provided a genome-wide association hit or robust candidate gene, and that future analyses of hyperactive/impulsive symptoms across age ranges could be useful.
- Evident from the text: this is a review of published studies rather than new primary data, and key methodological details and full statistical tables are relegated to supplementary material not included in the provided text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 18 cited sources checked · 0 supported · 0 flagged
- Findingnone given
In aADHD, MAOB, which encodes the enzyme that metabolizes dopamine, was more strongly associated.
“In aADHD MAOB, which encodes the enzyme that metabolizes dopamine, was more strongly associated.”
Quote in the paperSubstantial claim - Findingcitation
The oxidative stress system is a major actor involved in both cADHD and aADHD.
“The involvement of the oxidative stress system as major actor followed by some dopamine metabolism enzymes (DBH, DDC), DISC1, microRNA and adiponectin in cADHD and in aADHD strengthens the hypothesis that dysregulation of oxidative stress mechanisms as well as of dopamine metabolism are implicated in ADHD independently of age.”
Quote in the paperSubstantial claim - Findingown data
Circadian rhythms genes, MAOB, HTR2A, BCHE, SNAP25, BAIAP2, NOS1, KCNIP4, SPOCK3 are specific for aADHD.
“whereas circadian rhythms genes, MAOB, HTR2A, BCHE, SNAP25, BAIAP2, NOS1, KCNIP4, SPOCK3 are specific for aADHD (p=0.007; OR=3.30 95%CI:1.33–8.29, Table S2).”
Quote in the paperSubstantial claim - Findingreasoning
Our results confirm the involvement of this system throughout lifespan.
“Our results confirm the involvement of this system throught lifespan.”
Quote in the paperSubstantial claim - Findingown data
The systematic search identified 350 eligible studies from genomics and metabolomics for cADHD and 91 for aADHD.
“From a PRISMA flow-chart, a total of eligibility 350 studies from genomics and metabolomics were found for cADHD and 91 for aADHD.”
- Also stated in: § Results · plain
“As indicated in the PRISMA flow-chart, a total of eligibility was 350 studies from genomics and metabolomics for cADHD and 91 for aADHD (Figure 1).”
Quote in the paperNot a substantial claim - Also stated in: § Results · plain
- Findingown data
MAD, SOD, PON1, ARES, TOS, TAS, OSI, followed by DISC1, DBH, DDC, microRNA and adiponectin are common between cADHD and aADHD.
“Moreover we detected some genes in common: MAD, SOD, PON1, ARES, TOS, TAS OSI, followed by DISC1, DBH, DDC, microRNA and adiponectin (Table S2).”
Quote in the paperSubstantial claim - Findingreasoning
Dopamine metabolism enzymes (DBH, DDC), DISC1, microRNA and adiponectin are involved in both cADHD and aADHD.
“The involvement of the oxidative stress system as major actor followed by some dopamine metabolism enzymes (DBH, DDC), DISC1, microRNA and adiponectin in cADHD and in aADHD strengthens the hypothesis that dysregulation of oxidative stress mechanisms as well as of dopamine metabolism are implicated in ADHD independently of age.”
Quote in the paperSubstantial claim - Findingown data
The review implicates OPRM1, adiponectin, KCNIP4, SPOCK3, microRNA, DIRAS2, DISC1, ZNF804A, ASTN2, GPC5/6, kynurenine pathway, CTNNA2, MAP1B, ITGAE/ITGA11.
“some genes implicated by our review should be replicated to yield definite conclusions: OPRM1, adiponectin, KCNIP4, SPOCK3, microRNA, DIRAS2, DISC1, ZNF804A, ASTN2, GPC5/6, kynurenine pathway, CTNNA2, MAP1B, ITGAE/ITGA11”
Quote in the paperSubstantial claim - Findingown data
SLC6A3, DRD4, MAOA, LPHN3, DIRAS2 and OPRM1 are specific for cADHD.
“Through a convergent functional genomic approach and statistical analyses, the results (Figure 2, Table 1) indicate that SLC6A3, DRD4, MAOA, LPHN3, DIRAS2 and OPRM1 are specific for cADHD (p=0.016; OR=2.27 95%CI:1.15–4.47, Table S2)”
Quote in the paperSubstantial claim - Premisecitation
Measures of oxidative stress were elevated among ADHD patients both children and adults.
“A meta-analysis concluded that measures of oxidative stress were elevated among ADHD patients both children and adults (Joseph et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Joseph et al. 2015
Not checked in the free run.
- Premisecitation
MAOA and MAOB were associated differentially to cADHD and aADHD respectively.
“Finally, MAOA and MAOB were associated differentially to cADHD and aADHD respectively (Ribases et al. 2009a), confirming our results.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ribases et al. 2009a
Not checked in the free run.
- Premisecitation
Several of these proteins appear to be under control of the stimulants methylphenidate and amphetamine that are used to treat ADHD symptoms.
“As reported in Poelmans et al. (2011) several of these proteins appear to be under control of the stimulants methylphenidate and amphetamine that are used to treat ADHD symptoms.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Poelmans et al. (2011)
Not checked in the free run.
- Interpretationreasoning
Dysregulation of oxidative stress mechanisms and dopamine metabolism are implicated in ADHD independently of age.
“The involvement of the oxidative stress system as major actor followed by some dopamine metabolism enzymes (DBH, DDC), DISC1, microRNA and adiponectin in cADHD and in aADHD strengthens the hypothesis that dysregulation of oxidative stress mechanisms as well as of dopamine metabolism are implicated in ADHD independently of age.”
Quote in the paperSubstantial claim - Interpretationreasoning
Specific genetic and biological mechanisms can differ with age.
“In summary, these data suggest that specific genetic and biological mechanisms can differ with age and suggest differential effects for dopaminergic and neurodevelopmental/neurite outgrowth systems in cADHD (SLC6A3, DRD4, MAOA, LPHN3, DIRAS2) and in aADHD (MAOB, BCHE, SNAP25, BAIAP2, NOS1, KCNIP4, SPOCK3).”
Quote in the paperSubstantial claim - Premisecitation
The list of ten candidate genes showing replicated evidence of association with cADHD includes SLC6A3 and DRD4.
“The list of ten candidate genes showing replicated evidence of association with cADHD (Hawi et al. 2015) includes SLC6A3 and DRD4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hawi et al. 2015
Not checked in the free run.
- Premisecitation
The list of ten candidate genes showing replicated evidence of association with ADHD included SNAP25 and NOS1.
“The list of ten candidate genes showing replicated evidence of association with ADHD included SNAP25 and NOS1 (Hawi et al. 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hawi et al. 2015
Not checked in the free run.
- Premisecitation
BAIAP2 was meta-analytically associated with aADHD.
“BAIAP2 was meta-analitic associated to aADHD (Bonvicini, Faraone, Scassellati 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bonvicini, Faraone, Scassellati 2016
Not checked in the free run.
- Premisecitation
LPHN3 is in the list of ten candidate genes showing replicated evidence of association with cADHD.
“LPHN3 is in the list of ten candidate genes showing replicated evidence of association with cADHD (Hawi et al. 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hawi et al. 2015
Not checked in the free run.
- Premisecitation
The 10R allele of the 40bp SLC6A3 VNTR is associated with cADHD.
“Gizer et al.’s meta-analysis reported an association between the 10R allele and cADHD (Gizer, Ficks, Waldman 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gizer, Ficks, Waldman 2009
Not checked in the free run.
- Interpretationreasoning
Some of these genes/proteins could be potential useful biomarkers to discriminate cADHD versus aADHD.
“Although the limitations, some of these genes/proteins could be potential useful biomarkers to discriminate cADHD versus aADHD.”
- Also stated in: § Common genes · hedged
“Although the limitations and the needing to confirm these results, some of these genes/proteins could be potential useful biomarkers to discriminate cADHD versus aADHD.”
Quote in the paperSubstantial claim- Rests on an assumption: The identification of biomarkers may facilitate the differential diagnosis of ADHD.
- Rests on an assumption: Peripheral biomarkers reflect the central biological mechanisms of ADHD.
- Also stated in: § Common genes · hedged
- Premisecitation
BCHE, SNAP25, BAIAP2, NOS1, KCNIP4 and SPOCK3 are implicated in neurite outgrowth, synaptic plasticity and neuronal proliferation/differentiation systems.
“BCHE, SNAP25, BAIAP2, NOS1, KCNIP4 and SPOCK3 are as whole implicated in the neurite outgrowth, synaptic plasticity and neuronal proliferation/differentiation systems that were already demonstrated to be involved in ADHD by the bioinformatic analyses of Poelmans et al. 2011 and Hawi et al. 2015.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Poelmans et al. 2011
Not checked in the free run.
- cites Hawi et al. 2015
Not checked in the free run.
- May combine two claims. 12
- Classified as probably not a substantial claim. 7
May combine two claims.
Findingnone givenSNPs-CNVs-GWAS studies available for a gene showed mostly negative results for children, and more genes resulted in associations with aADHD.
“Moreover, as the SNPs-CNVs-GWAS studies available for a gene showed mostly negative results for children, more genes resulted in associations with aADHD”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn common among cADHD and aADHD, the most significant findings are for oxidative stress proteins (MAD, SOD, PON1, ARES, TOS, TAS, OSI), and, in the second level, DISC1, DBH, DDC, microRNA and adiponectin.
“In common among cADHD and aADHD, the most significant findings are for oxidative stress proteins (MAD, SOD, PON1, ARES, TOS, TAS, OSI), and, in the second level, DISC1, DBH, DDC, microRNA and adiponectin.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor cADHD, associations were found for genes belonging to dopaminergic (SLC6A3, DRD4, MAOA) and neurodevelopmental (LPHN3, DIRAS2) systems and OPRM1 (Yates corrected p=0.016; OR=2.27 95%CI 1.15-4.47).
“For children, associations were found for genes belonging to dopaminergic (SLC6A3, DRD4, MAOA) and neurodevelopmental (LPHN3, DIRAS2) systems and OPRM1 (Yates Corrected p=0.016; OR=2.27 95%CI:1.15–4.47).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenFewer studies were performed for KCNIP4, SPOCK3, and DIRAS2 genes.
“Fewer studies were performed for KCNIP4, SPOCK3, and DIRAS2 genes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenAll genetic studies performed in childhood and/or adulthood ADHD so far are characterized by a lack of power and their results have not provided genome-wide association hit or robust candidate gene.
“all genetic studies performed in childhood and/or adulthood ADHD so far are characterized by a lack of power and their results have not provided genome-wide association hit or robust candidate gene”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor aADHD, studies implicated circadian rhythms genes, HTR2A, MAOB and a more generic neurodevelopmental/neurite outgrowth network (BCHE, SNAP25, BAIAP2, NOS1/NO, KCNIP4, SPOCK3; Yates corrected p=0.007; OR=3.30 95%CI 1.33-8.29).
“Studies of adults have implicated circadian rhythms genes, HTR2A, MAOB and a more generic neurodevelopmental/neurite outgrowth network (BCHE, SNAP25, BAIAP2, NOS1/NO, KCNIP4, SPOCK3; Yates Corrected p=0.007; OR= 3.30 95%CI:1.33–8.29).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe 9R allele of the 40bp SLC6A3 VNTR is associated with aADHD, although not significant after Bonferroni correction.
“One associates, even though not significant after Bonferroni correction, the 9R allele of the 40bp SLC6A3 VNTR with aADHD (Bonvicini, Faraone, Scassellati 2016)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bonvicini, Faraone, Scassellati 2016
Not checked in the free run.
May combine two claims.
Interpretationown dataThe review found some divergence in findings between cADHD and aADHD, which suggests differential etiological pathways for different age ranges.
“Consistently with a developmental twin study where different sources of additive genetic variance accounted for the expression of ADHD in childhood and adulthood (Chang et al. 2013), our review found some divergence in findings between cADHD and aADHD, which suggests differential etiological pathways for different age ranges.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chang et al. 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA systematic search up until February 2016 was conducted.
“A systematic search (up until February, 2016) was conducted.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationBoth stimulants have been shown to stimulate neurite outgrowth and directly or indirectly regulate the expression and/or function of several genes/proteins implicated in this network.
“Both stimulants have been shown to stimulate neurite outgrowth and directly or indirectly regulate the expression and/or funtion of several genes/proteins implicated in this network.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Poelmans et al. (2011)
Not checked in the free run.
May combine two claims.
InterpretationreasoningThere are some genes whose effects do not differ throughout lifetime, whereas others are linked to age specific stages.
“There are some genes whose effects do not differ throughout lifetime, whereas others are linked to age specific stages.”
Quote in the paperSubstantial claim- Rests on an assumption: SNAP25 plays an important role in axonal growth, synaptic plasticity and neurotransmitter release, acting in essential steps for wiring the nervous system.
- Rests on an assumption: NOS1 influences cadherin systems and plays a direct role in neurite outgrowth.
May combine two claims.
PremisecitationThe DRD4 7R allele is associated with cortical thickness trajectories in early development, but this association was no longer found around 16-18 years of age.
“Moreover, the DRD4 7R allele is associated with cortical thickness trajectories in early development but this association was no longer found around 16–18 years of age (Shaw et al. 2007; Shaw et al. 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Shaw et al. 2007
Not checked in the free run.
- cites Shaw et al. 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA hypothetical signature of genetic and biochemical markers that might someday be useful for diagnosing ADHD in childhood includes SLC6A3, DRD4 and MAOA.
“This signature includes SLC6A3, DRD4 and MAOA, which is consistent with our conclusions.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Faraone, Bonvicini, Scassellati 2014
Not checked in the free run.
- cites Scassellati and Bonvicini 2015
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductreasoningTo give the same weight to the different findings (single study and meta-analysis), each meta-analysis available for a certain gene or protein was divided into single studies.
“to give the same weight to the different findings (single study and meta-analysis), we divided each meta-analysis available for a certain gene or protein, into single studies.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOxidative stress predisposes to a diverse range of psychiatric conditions, including ADHD.
“Research suggests that oxidative stress predispones to a diverse range of psychiatric conditions, including ADHD (Joseph et al. 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Joseph et al. 2015
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningThese mechanisms could be linked to a potential differential effect in the developing (LPHN3 and DIRA2) and adult (BCHE, SNAP25, BAIAP2, NOS1, KCNIP4, SPOCK3) brain.
“These mechanisms, which are believed to underpin processes relevant for ADHD such as cognitive performance, attention, learning and memory formation, could be linked to a potential differential effect in the developing (LPHN3 and DIRA2) and adult (BCHE, SNAP25, BAIAP2, NOS1, KCNIP4, SPOCK3) brain.”
Quote in the paperSubstantial claim- Rests on an assumption: The neurite outgrowth, synaptic plasticity and neuronal proliferation/differentiation mechanisms underpin processes relevant for ADHD such as cognitive performance, attention, learning and memory formation.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningThese specific associations could reflect a certain versatility of these genes throughout the lifespan, first with a less significant role on early brain development and a larger role later in the lifecycle.
“These specific associations could reflect a certain versatility of these genes throughout the lifespan, first with a less significant role on early brain development and a larger role later in the lifecycle.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningDifferential effects exist for dopaminergic and neurodevelopmental/neurite outgrowth systems in cADHD (SLC6A3, DRD4, MAOA, LPHN3, DIRAS2) and in aADHD (MAOB, BCHE, SNAP25, BAIAP2, NOS1, KCNIP4, SPOCK3).
“In summary, these data suggest that specific genetic and biological mechanisms can differ with age and suggest differential effects for dopaminergic and neurodevelopmental/neurite outgrowth systems in cADHD (SLC6A3, DRD4, MAOA, LPHN3, DIRAS2) and in aADHD (MAOB, BCHE, SNAP25, BAIAP2, NOS1, KCNIP4, SPOCK3).”
Quote in the paperSubstantial claim- Rests on an assumption: SNAP25 plays an important role in axonal growth, synaptic plasticity and neurotransmitter release, acting in essential steps for wiring the nervous system.
- Rests on an assumption: NOS1 influences cadherin systems and plays a direct role in neurite outgrowth.
May combine two claims.
InterpretationreasoningThe effects of some genes do not change throughout lifetime, whereas others are linked to age specific stages.
“The effects of some genes do not change throughout lifetime, whereas others are linked to age specific stages.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The identification of biomarkers may facilitate the differential diagnosis of ADHD.
“The identification of biomarkers may facilitate the differential diagnosis of ADHD.”
The paper relies on this without support.
Peripheral biomarkers reflect the central biological mechanisms of ADHD.
“The results of a recent meta-analysis of childhood ADHD studies identified some potential peripheral biomarkers linked to monoaminergic pathways and to the HPA axis (Scassellati et al. 2012).”
The paper relies on this without support.
The neurite outgrowth, synaptic plasticity and neuronal proliferation/differentiation mechanisms underpin processes relevant for ADHD such as cognitive performance, attention, learning and memory formation.
“These mechanisms, which are believed to underpin processes relevant for ADHD such as cognitive performance, attention, learning and memory formation”
The paper relies on this without support.
SNAP25 plays an important role in axonal growth, synaptic plasticity and neurotransmitter release, acting in essential steps for wiring the nervous system.
“SNAP25 plays an important role in axonal growth, synaptic plasticity and neurotransmitter release, acting in essential steps for wiring the nervous system.”
The paper relies on this without support.
NOS1 influences cadherin systems and plays a direct role in neurite outgrowth.
“NOS1 influences cadherin systems and plays a direct role in neurite outgrowth.”
The paper relies on this without support.
DISC1 is implicated in neuronal migration, neurite outgrowth and axon targeting during brain development.
“More findings should be carried out on DISC1, a gene implicated in neuronal migration, neurite outgrowth and axon targeting during brain development.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Familial history has been found to be the most significant risk factor for the emergence and persistence of ADHD.
“As reviewed above, familial history has been found to be the most significant risk factor for the emergence and persistence of ADHD (Chang et al., 2013; Bonvicini et al., 2018; Uchida et al., 2018).”
From A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD) (2019) · cites this paper as Bonvicini et al., 2018
The Introduction (page unavailable) discusses substantial ADHD heritability and reports that 65% of affected children continue to have symptoms into adulthood. It does not identify family history as a risk factor for persistence or rank it as the most significant risk factor for ADHD’s emergence. (LLM, conf=0.77)
Experimental — accuracy not yet measuredWhile child and adult aggression are genetically similar, some genetic factors underlying ADHD in children and later life may be different.
“suggesting that while child and adult aggression are genetically similar, it is conceivable that some genetic factors underlying ADHD in children and later life may be different [32]”
From Genetics of child aggression, a systematic review (2024) · cites this paper as [32]
The Discussion (page not provided) reports different genetic findings for childhood and adult ADHD and suggests that their etiological pathways may differ. It does not address whether child and adult aggression are genetically similar, so that part of the cited sentence is unsupported by this source. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
BCHE is called adult-specific despite a childhood association
MajorThe paper describes BCHE as the stronger association among genes affected by a deletion in childhood ADHD, but subsequently calls BCHE specific to adult ADHD.
“circadian rhythms genes, MAOB, HTR2A, BCHE, SNAP25, BAIAP2, NOS1, KCNIP4, SPOCK3 are specific for aADHD”
“BCHE. Elia et al. (2010); Lesch et al. (2011); Lionel et al. (2011) gave evidence for a 3q26.1 deletion and among the involved genes, BCHE showed the stronger association in cADHD.”
The citation lists haven’t been fetched yet
References 116 · Cited by 83
Research works printed but not linked: 4
- Corominas-Roso M, 2013, Int J Neuropsychopharmacol, 30, 1
- Drtilkova I, 2008, Neuro Endocrinol Lett, 29, 320
- Gao Q, 2014, Shanghai Arch Psychiatry, 26, 194
- Kayyal M, 2015, Pak J Med Sci, 31, 1162
- Authors
- Bonvicini, C., Faraone, S. V., & Scassellati, C.
- Affiliations
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- SUNY Upstate Medical University (US)
- Corresponding author
- Scassellati, Catia
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2017-02-24
- Volume
- 19
- Issue
- 2
- Pages
- 80-100
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- PMC
- PMC5568996
- OpenAlex
- W2574544988
- Semantic Scholar
- e1e231d2bdbb5f9e9c2e1dd0fabd0ed60283e23c
- Cited by
- 83
- References
- 116
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 11 · 2023: 11 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 7 · 2018: 5 · 2017: 5
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Figshare (cc-by)
- Funders
- Italian Ministry of Health
- K.G. Jebsen Centre for Research on Neuropsychiatric Disorders
- European Union’s Seventh Framework Programme for research (602805)
- NIMH (R01MH094469)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- attention deficit hyperactivity disorder, childhood ADHD, adult ADHD, genetic biomarkers, peripheral biomarkers, dopaminergic genes, dopamine transporter, DRD4, monoamine oxidase A, LPHN3, OPRM1, circadian rhythm genes, HTR2A, monoamine oxidase B, neurodevelopmental genes, oxidative stress, microRNA, adiponectin, metabolomics, functional genomics
- MeSH terms
- Adult, Attention Deficit Disorder with Hyperactivity, Child, Humans, Biomarkers, Genomics, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review